Testicular Cancer Information Center
Each year in the United States, more than 8000 men are diagnosed with testicular cancer. Thanks to improvements in treatment, however, testicular cancer patients are living longer. It is estimated that there are more than 184,000 testicular cancer survivors in the U.S. today.
Advances in surgery, chemotherapy, and radiation therapy have contributed to improved testicular cancer survival. In addition, advances in supportive care have made testicular cancer treatment more tolerable, leading to improved quality of life.
Understanding testicular cancer treatment options, the role of different doctors specializing in the treatment of testicular cancer, and how and when to access new and innovative testicular cancer treatment options available through clinical trials is essential in order to achieve the best outcome from testicular cancer treatment.
The Cancer Consultants Testicular Cancer Information Center has been designed to help patients understand testicular cancer and testicular cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of testicular cancer.
Headline Testicular Cancer News 
CancerConnect Live Web Chat with Dr. Barrie Cassileth from Memorial Sloan-Kettering Cancer Center on Complementary Cancer Therapies on Thursday, November 17th at 6PM EST
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service;...
Clinical Trial Participation Is Inadequate
Some populations are under-represented
Stay on Top of Your Family History of Cancer
As family history changes over time it may affect how you should be screened for cancer.
Testicular Cancer Tips
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Testicular Cancer Management
Inspiration, Hope & Resources
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Testicular Cancer Clinical Trials
REFMAL28-Ts – A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-Ts
REFMAL39 – A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
REFMAL30-TS – PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-TS
 |
 |
 |
 |
